Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 16 filers reported holding Astellas Pharma Inc in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,000 | -68.8% | 393 | -68.1% | 0.00% | -50.0% |
| Q1 2017 | $16,000 | -68.0% | 1,231 | -65.9% | 0.00% | -71.4% |
| Q4 2016 | $50,000 | -99.5% | 3,612 | -99.5% | 0.01% | -99.5% |
| Q3 2016 | $10,254,000 | -3.5% | 659,892 | -3.1% | 1.47% | -7.1% |
| Q2 2016 | $10,624,000 | +12.9% | 681,170 | -3.6% | 1.58% | +19.4% |
| Q1 2016 | $9,409,000 | -6.0% | 706,680 | +1.6% | 1.33% | -5.7% |
| Q4 2015 | $10,013,000 | +86.9% | 695,666 | +67.5% | 1.41% | +75.6% |
| Q3 2015 | $5,358,000 | -3.9% | 415,359 | +6.2% | 0.80% | +7.7% |
| Q2 2015 | $5,577,000 | -10.5% | 390,951 | +2.9% | 0.74% | -14.9% |
| Q1 2015 | $6,234,000 | +15.1% | 380,011 | -1.3% | 0.88% | +17.8% |
| Q4 2014 | $5,414,000 | +0.2% | 384,899 | +6.1% | 0.74% | -5.1% |
| Q3 2014 | $5,402,000 | +3.6% | 362,864 | -8.5% | 0.78% | +7.4% |
| Q2 2014 | $5,212,000 | +3.2% | 396,665 | -6.6% | 0.73% | +1.4% |
| Q1 2014 | $5,050,000 | +0.5% | 424,879 | +25.3% | 0.72% | -0.6% |
| Q4 2013 | $5,024,000 | +19.7% | 339,011 | +2.9% | 0.72% | +18.7% |
| Q3 2013 | $4,197,000 | -3.3% | 329,446 | +2.9% | 0.61% | -12.6% |
| Q2 2013 | $4,342,000 | – | 320,050 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE GROUP LLC | 391,745 | $5,438,880 | 0.25% |
| Cassady Schiller Wealth Management, LLC | 698 | $9,667 | 0.01% |
| MAI Capital Management | 19,087 | $264,362 | 0.00% |
| SVB WEALTH LLC | 10,472 | $145,037 | 0.00% |
| RHUMBLINE ADVISERS | 34,759 | $481,408 | 0.00% |
| First Horizon Advisors, Inc. | 114 | $1,578 | 0.00% |
| Operose Advisors LLC | 90 | $1,247 | 0.00% |
| Russell Investments Group, Ltd. | 783 | $10,845 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 166 | $2,299 | 0.00% |